Cargando…

Direct and indirect anti-leukemic properties of activity-on-target interferons for the treatment of T-cell acute lymphoblastic leukemia

Detalles Bibliográficos
Autores principales: Goossens, Steven, Cauwels, Anje, Pieters, Tim, De Smedt, Renate, T’Sas, Sara, Almeida, André, Daneels, Willem, Van Vlierberghe, Pieter, Tavernier, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152961/
https://www.ncbi.nlm.nih.gov/pubmed/34647441
http://dx.doi.org/10.3324/haematol.2021.278913
_version_ 1784717750908747776
author Goossens, Steven
Cauwels, Anje
Pieters, Tim
De Smedt, Renate
T’Sas, Sara
Almeida, André
Daneels, Willem
Van Vlierberghe, Pieter
Tavernier, Jan
author_facet Goossens, Steven
Cauwels, Anje
Pieters, Tim
De Smedt, Renate
T’Sas, Sara
Almeida, André
Daneels, Willem
Van Vlierberghe, Pieter
Tavernier, Jan
author_sort Goossens, Steven
collection PubMed
description
format Online
Article
Text
id pubmed-9152961
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Fondazione Ferrata Storti
record_format MEDLINE/PubMed
spelling pubmed-91529612022-06-13 Direct and indirect anti-leukemic properties of activity-on-target interferons for the treatment of T-cell acute lymphoblastic leukemia Goossens, Steven Cauwels, Anje Pieters, Tim De Smedt, Renate T’Sas, Sara Almeida, André Daneels, Willem Van Vlierberghe, Pieter Tavernier, Jan Haematologica Letter to the Editor Fondazione Ferrata Storti 2021-10-14 /pmc/articles/PMC9152961/ /pubmed/34647441 http://dx.doi.org/10.3324/haematol.2021.278913 Text en Copyright© 2022 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Letter to the Editor
Goossens, Steven
Cauwels, Anje
Pieters, Tim
De Smedt, Renate
T’Sas, Sara
Almeida, André
Daneels, Willem
Van Vlierberghe, Pieter
Tavernier, Jan
Direct and indirect anti-leukemic properties of activity-on-target interferons for the treatment of T-cell acute lymphoblastic leukemia
title Direct and indirect anti-leukemic properties of activity-on-target interferons for the treatment of T-cell acute lymphoblastic leukemia
title_full Direct and indirect anti-leukemic properties of activity-on-target interferons for the treatment of T-cell acute lymphoblastic leukemia
title_fullStr Direct and indirect anti-leukemic properties of activity-on-target interferons for the treatment of T-cell acute lymphoblastic leukemia
title_full_unstemmed Direct and indirect anti-leukemic properties of activity-on-target interferons for the treatment of T-cell acute lymphoblastic leukemia
title_short Direct and indirect anti-leukemic properties of activity-on-target interferons for the treatment of T-cell acute lymphoblastic leukemia
title_sort direct and indirect anti-leukemic properties of activity-on-target interferons for the treatment of t-cell acute lymphoblastic leukemia
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152961/
https://www.ncbi.nlm.nih.gov/pubmed/34647441
http://dx.doi.org/10.3324/haematol.2021.278913
work_keys_str_mv AT goossenssteven directandindirectantileukemicpropertiesofactivityontargetinterferonsforthetreatmentoftcellacutelymphoblasticleukemia
AT cauwelsanje directandindirectantileukemicpropertiesofactivityontargetinterferonsforthetreatmentoftcellacutelymphoblasticleukemia
AT pieterstim directandindirectantileukemicpropertiesofactivityontargetinterferonsforthetreatmentoftcellacutelymphoblasticleukemia
AT desmedtrenate directandindirectantileukemicpropertiesofactivityontargetinterferonsforthetreatmentoftcellacutelymphoblasticleukemia
AT tsassara directandindirectantileukemicpropertiesofactivityontargetinterferonsforthetreatmentoftcellacutelymphoblasticleukemia
AT almeidaandre directandindirectantileukemicpropertiesofactivityontargetinterferonsforthetreatmentoftcellacutelymphoblasticleukemia
AT daneelswillem directandindirectantileukemicpropertiesofactivityontargetinterferonsforthetreatmentoftcellacutelymphoblasticleukemia
AT vanvlierberghepieter directandindirectantileukemicpropertiesofactivityontargetinterferonsforthetreatmentoftcellacutelymphoblasticleukemia
AT tavernierjan directandindirectantileukemicpropertiesofactivityontargetinterferonsforthetreatmentoftcellacutelymphoblasticleukemia